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Background: While optimal cardiovascular risk factor (CRF) proﬁle is associated with lower mortality, morbidity,
and healthcare expenditures among individuals with atherosclerotic cardiovascular disease (ASCVD), less is
known regarding its impact on ﬁnancial hardship from medical bills. Therefore, we assessed whether an optimal
CRF proﬁle is associated with a lower burden of ﬁnancial hardship from medical bills and a reduction in costrelated barriers to health.
Methods: We used a nationally representative sample of adults between 18 and 64 years from the National Health
Interview Survey between 2013 and 2017. We assessed ASCVD status and the number of risk factors to categorize
the study population into 4 mutually exclusive categories: ASCVD (irrespective of CRF proﬁle) and non-ASCVD
with poor, average, and optimal CRF proﬁle. Adjusted logistic regression model was used to determine the association of ASCVD/CRF proﬁle with ﬁnancial hardship from medical bills and cost-related barriers to health
(cost-related medication non-adherence (CRN), foregone/delayed care, and high ﬁnancial distress).
Results: We included 119,388 non-elderly adults, representing 189 million individuals annually across the United
States. Non-ASCVD/optimal CRF proﬁle individuals had a lower prevalence of ﬁnancial hardship and an inability
paying medical bills when compared with individuals with ASCVD (24% vs 45% and 6% vs 19%, respectively).
Among individuals without ASCVD and an optimal CRF proﬁle, the prevalence of each cost-related barrier to
health was <50% compared with individuals with ASCVD. Poor/low income and uninsured individuals within
non-ASCVD/average CRF proﬁle strata had a lower prevalence of ﬁnancial hardship and an inability paying
medical bills when compared with middle/high income and insured individuals with ASCVD. Non-ASCVD individuals with optimal CRF proﬁle had the lowest odds of all barriers to health.
Conclusion: Optimal CRF proﬁle is associated with a lower prevalence of ﬁnancial hardship from medical bills and
cost-related barriers to health despite lower income and lack of insurance.
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1. Introduction

2.3. Outcome variables

Atherosclerotic cardiovascular disease (ASCVD) remains a leading
cause of morbidity and mortality in the United States and around the
world. Patients with ASCVD endure signiﬁcant ﬁnancial burden from
direct and indirect medical costs, life-years lost, and diminished quality
of life related to their condition [1]. In 2010, the American Heart Association launched the 2020 Strategic Impact Goals, which deﬁned the
concept of ideal cardiovascular health (CVH), including adequate management of hypertension, diabetes, and total cholesterol, smoking
abstinence, maintaining a healthy weight and diet, and engaging in
physical activity [2]. It is now well established that an optimal cardiovascular risk factor (CRF) proﬁle, as a measure of CVH, is associated with
favorable cardiovascular outcomes, including lower mortality and
morbidity rates [3–6], as well as decreased healthcare expenditures and
cardiovascular costs later in life, regardless of ASCVD status [7–9]. To
date, however, less is known whether an optimal CRF proﬁle is associated
with lower ﬁnancial hardship among affected individuals. Therefore, in
this study we sought to describe ﬁnancial hardship from medical bills
across the spectrum of varying CRF proﬁles and an ASCVD status from a
nationally representative sample of adults in the United States (US).
Additionally, we analyzed cost-related consequences and barriers
affecting individuals’ health, such as cost-related medication
non-adherence (CRN), foregone/delayed care, and high ﬁnancial
distress.

2.3.1. Financial hardship from medical bills
Individuals were classiﬁed as having “ﬁnancial hardship from medical bills” if they answered “yes” to either of the following questions: “In
the past 12 months did you/anyone in your family have problems paying or
were unable to pay any medical bills? Include bills for doctors, dentists, hospitals, therapists, medication, equipment, nursing home or home care” and
“Do you/anyone in your family currently have any medical bills that are being
paid off over time? This could include medical bills being paid off with a credit
card, through personal loans, or bill paying arrangements with hospitals or
other providers. The bills can be from earlier years as well as this year.” Individuals who answered “yes” to having any problems paying bills were
then asked a follow-up question: “Do you/Does anyone in your family
currently have any medical bills that you are unable to pay at all?” Those
who answered “yes” to the follow-up question were classiﬁed as “unable
to pay medical bills at all”, a proxy of the most vulnerable individuals.
2.3.2. Cost-related barriers to health
Individuals who reported money-saving behaviors in the past 12 months
as described in Table 1, were deﬁned to have CRN. Individuals who reported
to have delayed care or have not sought out care because they could not
afford it or because they were worried about the costs in the past 12 months
were deﬁned to have foregone/delayed care (Table 1) [10]. Financial
distress was derived from 6 questions addressing “worry” regarding several
ﬁnancial matters in the past 12 months as mentioned in Table 1. All questions were answered on a 4-point scale, ranging from 0 (not worried at all) to
4 (very worried). An aggregate score was created, ranging from 6 to 24, with
a higher score translating into higher stress [11], which was divided into
quartiles. Individuals among the highest quartile (i.e. those with the highest
scores) were then classiﬁed as having high ﬁnancial distress.

2. Materials & methods
2.1. Study design
We utilized pooled, cross-sectional data from the National Health
Interview Survey (NHIS) between 2013 and 2017. The NHIS is a National
Center for Health Statistics/Center for Disease Control and Prevention
database constructed from annual surveys, which incorporates complex,
multi-stage sampling to provide estimates on the noninstitutionalized US
population. This study was based on the Sample Adult Core ﬁles, which
were supplemented with demographic and socioeconomic characteristics, health status, healthcare services, and health-related behaviors from
the US adult population. Since NHIS data is publicly available as deidentiﬁed data, this study was exempt from the Institutional Review
Board Committee. We limited our study to focus on non-elderly (18–64
years of age) adults with ASCVD status and CRF proﬁle information to
capture the population without universal public insurance, which may
provide enhanced protection from the ﬁnancial-related outcomes of
interest.

2.4. Covariates
Other covariates included in this study were age (18–39 and 40–64
years), sex, family size (0, 1, and 2), family income (middle/high
Table 1
Itemized questions for Cost-related Barriers to Health.
Cost-related Medication Non-adherence
During the past 12 months, were any of the following true for you? (Yes/No)
1 You skipped medication doses to save money
2 You took less medicine to save money
3 You delayed ﬁlling a prescription to save money
Forgone/Delayed Care
During the past 12 months, were any of the following true for you? (Yes/No)
1 Has medical care been delayed for you because of worry about the cost? (Do not
include dental care)
2 Was there any time when you needed medical care, but did not get it because you
couldn’t afford it?
3 Was there any time when you needed any of the following, but didn’t get it because
you couldn’t afford it?
a Prescription medicines
b. Mental healthcare or counseling
c. Dental care
d. Eyeglasses
e To see a specialist
f. Follow-up care

2.2. Study variable
2.2.1. ASCVD and CRF proﬁles
Individuals who self-reported having coronary artery disease
(answered “yes” to any of the following 3 questions: “Have you ever been
told by a doctor or other health professional that you had … coronary heart
disease? or … angina, also called angina pectoris? or … a heart attack (also
called myocardial infarction)?”) and/or stroke disease (answered “yes” to
the following question: “Have you ever been told by a doctor or other health
professional that you had a stroke?”), were established as having ASCVD.
CRF proﬁle was ascertained based on the presence of 1 or more of the
following self-reported clinical characteristics: diagnosis of hypertension,
diabetes mellitus, or high cholesterol, current smoker, obesity (body
mass index  30 kg/m2), or insufﬁcient physical activity (75 min/week
of vigorous-intensity activity or 150 min/week moderate-intensity activity or combination) [2]. The sum of the risk factors an individual
accrued was used to determine the CRF proﬁle: “poor/unfavorable” (4
CRFs) and “favorable” (<4 CRFs) (“average” [2–3 CRFs] or “optimal”
[0–1 CRF]).

High Financial Distress
How worried (very worried, moderately worried, not too worried, not worried at all)
are you right now about
1 Not having enough money for retirement?
2 Not being able to pay medical costs of a serious illness or accident?
3 Not being able to maintain the standard of living you enjoy?
4 Not being able to pay medical costs for normal healthcare?
5 Not having enough to pay your normal monthly bills?
6 Not being able to pay your rent, mortgage, or other housing costs?
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conducted a sub-analysis among participants with ASCVD stratiﬁed by
CRF proﬁle status to ascertain unadjusted and adjusted associations with
ﬁnancial hardship from medical bills, an inability to pay bills at all, along
with the aforementioned barriers to health. We performed all statistical
analyses using Stata®, version 15.1 (StataCorp, LP, College Station,
Texas, USA). A two-tailed p-value of <0.05 was considered statistically
signiﬁcant for all analyses. All analyses were survey-speciﬁc and
considered the complex NHIS survey design.

income [200% federal poverty limit] and low/poor-income [<200%
federal poverty limit]), race/ethnicity (non-Hispanic white, nonHispanic black, non-Hispanic Asian, and Hispanic), insurance status
(insured and uninsured), education (at least some college education and
less than college education), region (Northeast, Midwest, South, and
West), and number of chronic comorbidities. Chronic comorbidities were
self-reported and included emphysema, chronic obstructive pulmonary
disease, asthma, gastrointestinal ulcer, cancer (any), arthritis (including
arthritis, gout, ﬁbromyalgia, rheumatoid arthritis, and systemic lupus
erythematosus), any kind of liver condition, and “weak/failing” kidneys,
were aggregated and categorized as having 0, 1, or  2.

3. Results
Our study population consisted of 119,388 individuals (between 18 and
64 years), representing 72% of total cohort surveyed by NHIS from 2013 to
2017. This sample represented 189 million non-elderly US adults annually.
Mean age was 41  7.7 years and 49% were men. Overall, 4.6% (95% CI:
4.4%, 4.8%) of the weighted study population had ASCVD. Among those
without ASCVD, 6% had a poor CRF proﬁle, 31.8% average CRF proﬁle, and
57.6% optimal CRF proﬁle. General characteristics of the study population
are displayed in Table 2. Non-ASCVD/optimal CRF proﬁle individuals were
younger (18–39 years old), from middle/high income families, with a lower
comorbidity count, and were more likely to have at least some college education when compared to individuals with ASCVD.

2.5. Statistical analysis
We utilized data from the Integrated Public Use Microdata Series
(http://www.ipums.org) to correctly calculate variance estimation for
nationally representative results, since 5 years of pooled data were used
for analysis. We divided the study population into 4 mutually exclusive
groups based on the ASCVD status and CRF proﬁle: ASCVD (irrespective
of the CRF proﬁle), non-ASCVD with poor CRF proﬁle, non-ASCVD with
average CRF proﬁle, and non-ASCVD with optimal CRF proﬁle. We
compared the baseline characteristics of the study population using χ2
analysis across the pre-speciﬁed ASCVD/CRF proﬁle groups and studied
the prevalence using weighted proportions. We used logistic regression
model adjusted for age, sex, family size, family income, race/ethnicity,
insurance status, education, comorbidities, and region to calculate odds
ratios to determine the association of ASCVD/CRF proﬁle on ﬁnancial
hardship from medical bills, and cost-related barriers to health (CRN,
foregone/delayed care, and high ﬁnancial distress). Additionally, we

3.1. Burden of ASCVD and non-ASCVD/CRF proﬁle on ﬁnancial hardship
Fig. 1 depicts the prevalence of ﬁnancial hardship from medical bills
and an inability to pay bills. Nearly half (45.2%) of the individuals with
ASCVD had ﬁnancial hardship from medical bills and 19% were unable
to pay medical bills at all. In contrast, individuals without ASCVD and an

Table 2
General characteristics of the study population by ASCVD and non-ASCVD/CRF proﬁle status.
Total

Sample (N)
Weighted sample, (weighted %)
Age Category, n (weighted %)
18-39
40-64
Sex, n (weighted %)
Male
Female
Race/Ethnicity, n (weighted %)
Non-Hispanic White
Non-Hispanic Black
Non-Hispanic Asian
Hispanic
Family Size, n (weighted %)
1
2
3
Family Income, n (weighted %)
Middle/High-Income
Poor/Low-Income
Insurance Status, n (weighted %)
Insured
Uninsured
Education, n (weighted %)
Some College or Higher
HS/GED or Less than HS
Region, n (weighted %)
Northeast
Midwest
South
West
Comorbidities, n (weighted %)
0
1
2

ASCVD

No ASCVD

p-value

Poor
CRF Proﬁle

Average
CRF Proﬁle

Optimal
CRF Proﬁle

119,388
188,861,117

6160
8,696,486 (4.6)

7878
11,381,648 (6.0)

38,768
60,102,341 (31.8)

66,582
108,680,642 (57.6)

54,192 (47.6)
65,196 (52.4)

684 (12.4)
5476 (87.6)

1061 (13.9)
6817 (86.1)

14,010 (37.9)
24,758 (62.1)

38,437 (59.3)
28,145 (40.7)

55,045 (49.0)
64,343 (51.0)

3317 (57.5)
2843 (42.5)

3445 (47.7)
4433 (52.3)

17,661 (49.3)
21,107 (50.7)

30,622 (48.3)
35,960 (51.7)

73,736 (63.4)
16,316 (12.9)
7219 (6.2)
20,466 (17.5)

3945 (67.1)
1118 (16.4)
159 (2.8)
799 (13.7)

4844 (65.8)
1583 (17.3)
197 (2.8)
1093 (14.1)

23,632 (63.1)
6207 (14.8)
1571 (4.5)
6725 (17.5)

41,315 (62.9)
7408 (11.2)
5292 (7.7)
11,849 (18.1)

36,025 (17.0)
33,903 (28.8)
49,460 (54.2)

2423 (22.9)
2095 (38.1)
1642 (39.0)

2768 (19.6)
2682 (37.5)
2428 (42.9)

10,970 (15.7)
11,775 (30.6)
16,023 (53.7)

19,864 (17.0)
17,351 (26.2)
29,367 (56.8)

71,353 (68.6)
41,033 (31.4)

2690 (53.8)
3137 (46.2)

4001 (59.8)
3474 (40.2)

21,843 (64.5)
14,561 (35.5)

42,819 (73.0)
19,861 (27.0)

100,559 (85.5)
18,268 (14.5)

5407 (88.2)
731 (11.8)

6908 (88.3)
944 (11.7)

31,890 (83.5)
6724 (16.5)

56,354 (86.2)
9869 (13.8)

76,488 (64.2)
42,513 (35.8)

3057 (51.1)
3081 (48.9)

3902 (50.3)
3939 (49.7)

21,988 (56.8)
16,613 (43.2)

47,541 (70.8)
18,880 (29.2)

18,904
25,812
42,569
32,103

(17.4)
(22.4)
(36.5)
(23.7)

907 (15.2)
1370 (24.4)
2588 (42.4)
1295 (18.0)

1154
1810
3228
1686

(15.8)
(24.1)
(41.5)
(18.6)

5943 (16.7)
8872 (23.7)
14,602 (38.8)
9351 (20.7)

10,900 (18.1)
13,760 (21.4)
22,151 (34.3)
19,771 (26.3)

76,882 (66.2)
29,432 (24.1)
13,074 (9.7)

1880 (32.7)
1862 (31.0)
2418 (36.3)

2886 (38.4)
2755 (35.1)
2237 (26.5)

22,891 (61.0)
10,878 (27.4)
4999 (11.6)

49,225 (74.6)
13,937 (20.6)
3420 (4.8)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor; HS, high school; GED, general equivalency diploma.
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optimal CRF proﬁle had a lower prevalence of ﬁnancial hardship from
medical bills (24.3%) and an inability paying medical bills (5.8%).
Among ASCVD and non-ASCVD/poor CRF proﬁle individuals, the prevalence of being unable to pay medical bills at all was 40% of those with
ﬁnancial hardship from medical bills when compared to only 24% among
non-ASCVD/optimal CRF proﬁle individuals. There was a stepwise
decrease in the prevalence of ﬁnancial hardship measures with
improving CRF among those without ASCVD. These differences persisted
among speciﬁc subpopulations as shown in Fig. 2. We found a higher
prevalence of ﬁnancial hardship and an inability to pay bills at all among
those with lower income and without insurance coverage across ASCVD/
CRF proﬁle strata. Furthermore, individuals with ASCVD among middle/
high income and insured strata, reported a higher prevalence of ﬁnancial
hardship from medical bills and an inability paying medical bills
compared to non-ASCVD/average CRF proﬁle individuals among poor/
low income and uninsured strata.
Table 3 details the adjusted odds ratios for ﬁnancial hardship from
medical bills across the spectrum of ASCVD and CRF proﬁle. Individuals
without ASCVD but with a favorable CRF proﬁle (optimal CRF proﬁle:
OR 0.44, 95% CI [0.41, 0.48]; average CRF proﬁle: OR 0.66, 95% CI
[0.61, 0.72]) had signiﬁcantly lower odds of having ﬁnancial hardship
from medical bills when compared to individuals with ASCVD; the association was similar for being unable to pay medical bills (Table 3). On
the other hand, those without established ASCVD and poor CRF proﬁle
had similar odds of experiencing ﬁnancial hardship from medical bills
(OR 0.90, 95% CI [0.82, 0.99]) or an inability paying medical bills (OR
0.89, 95% CI [0.78, 1.01]) as that of ASCVD individuals. This trend of
lower odds of ﬁnancial hardship and an inability to pay medical bills in
association with a more favorable CRF proﬁle persisted among all patient
and disease-related covariates (Tables S1 & S2).

those with lower income and without insurance coverage. After accounting for demographic and social risk factors, those without ASCVD
and optimal CRF proﬁle individuals had the lowest odds of having CRN
(OR 0.42, 95% CI [0.38, 0.48]), foregone/delayed care (OR 0.41 95% CI
[0.37, 0.45]), and high ﬁnancial distress (OR 0.52, 95% CI [0.47, 0.58]),
when compared to individuals with ASCVD. Conversely, those without
ASCVD and poor CRF had similar odds of experiencing all cost-related
barriers to health when compared to individuals with ASCVD (Table 4).
3.3. Burden of CRF proﬁle within ASCVD on ﬁnancial hardship and costrelated barriers to health
In a sub-analysis among those with ASCVD, we noticed a stepwise
decrease in the prevalence of all measures of ﬁnancial hardship and costrelated barriers to health with improving CRF proﬁle. Notably, the
prevalence of being unable to pay medical bills at all and CRN were 50%
lower among individuals with ASCVD and optimal CRF proﬁle when
compared with individuals with ASCVD and poor CRF proﬁle (unable to
pay medical bills at all: 11.5% vs 23.4%; CRN: 14.8% vs 27.3%).
Figures S1 & S2 illustrate the prevalence the outcomes by ASCVD and
CRF proﬁle status. These differences persisted after accounting for demographic and socioeconomic determinants of health (Table S3).
4. Discussion
In a nationally representative sample of US non-elderly adults, we
demonstrated that a favorable CRF proﬁle was associated with lower
ﬁnancial hardship from medical bills along with a reduction in previously
described barriers to health including CRN, foregone/delayed care, and
high ﬁnancial distress. Notably, we found that these results persisted
among all family income and insurance strata. Finally, our results showed
that an optimal CRF proﬁle was inversely associated with ﬁnancial
hardship from medical bills and an inability to pay medical bills at all
despite a lower income level and lack of insurance coverage.
In recent years with rising healthcare costs, ﬁnancial burden incurred
by patients and their families from medical bills has drawn signiﬁcant
national attention. It is now well established that individuals with ASCVD
face a particularly high healthcare-related ﬁnancial burden [12,13], with
1 in 10 families that have a member with ASCVD spending more than
one-third of their income on health-related expenses [13]. These expenses can represent major ﬁnancial challenges to patients, regardless of
their insurance status, and can lead to a reduction in overall quality of
health and psychological well-being along with other cost-related consequences and tradeoffs such as high ﬁnancial distress, medication
non-adherence, and foregone/delayed medical care [14,15]. The burden
of ﬁnancial hardship among individuals with ASCVD is worsened in the
presence of other comorbid conditions such as diabetes mellitus [16,29].
Established risk factors of cardiovascular disease – many of which can
be effectively modiﬁed, treated, or controlled – are important drivers of
death and disability. Due to their signiﬁcance and overall burden, the
AHA’s 2020 Strategic Impact Goals emphasized the importance of optimizing these risk factors as part of a national goal, to reduce CVD
morbidity, mortality, and economic burden. In recent years, multiple
reports have attempted to estimate the potential economic impact of a
favorable CRF proﬁle. Notably, Willis et al. studied the relationship between cardiovascular status, ideal cardiovascular metrics and healthcare
utilization in middle-aged individuals, and later-life healthcare costs [8].
They found that overall healthcare expenditures were signiﬁcantly lower
among those with a favorable CV health status. Similarly, Sullivan et al.
demonstrated that individuals without cardiometabolic risk factor clusters, on average, spent $5477 less on healthcare when compared with
those with cardiometabolic risk factor clusters [17]. In a nationally
representative US adult population, Valero-Elizondo et al. demonstrated
lower out-of-pocket costs among those with optimal CRF proﬁle irrespective of ASCVD status [7]. Importantly, these beneﬁts were noted
across all socioeconomic groups including those <65 years old.

3.2. Burden of ASCVD and non-ASCVD/CRF proﬁle on cost-related
barriers to health
Overall, all cost-related barriers to health measures were most prevalent among individuals with ASCVD followed by non-ASCVD individuals with poor CRF proﬁle (Fig. 3). These differences persisted
among speciﬁc subpopulations (Fig. 4), with a higher prevalence among

Fig. 1. Title: Prevalence of Financial Hardship from Medical Bills among NonElderly Adults by ASCVD and Non-ASCVD/CRF Proﬁle Status.
There was a stepwise increase in the prevalence of ﬁnancial hardship from
medical bills and an inability to pay bills at all with worsening CRF proﬁle.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.
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Fig. 2. Title: Prevalence of Financial Hardship from Medical Bills by (A), family income (B), insurance status among Non-Elderly Adults by ASCVD and Non-ASCVD/
CRF Proﬁle Status.
Within each CRF proﬁle strata, individuals with lower income and lack of insurance had a higher prevalence of ﬁnancial hardship from medical bills and an inability to
pay bills at all when compared with individuals with higher income and insurance coverage.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.

Table 3
Odds ratios of ﬁnancial hardship among non-elderly adults by ASCVD and nonASCVD/CRF proﬁle status.
ASCVD

OR (95%
CI)

No ASCVD
Poor CRF
Proﬁle

Average CRF
Proﬁle

Optimal CRF
Proﬁle

OR (95% CI)

OR (95% CI)

OR (95% CI)

0.63 (0.59, 0.68)

0.39 (0.36, 0.42)

0.66 (0.61, 0.72)

0.44 (0.41, 0.48)

0.50 (0.45, 0.55)

0.22 (0.20, 0.24)

0.56 (0.49, 0.63)

0.30 (0.26, 0.34)

Financial Hardship from Medical Bills
Model
Reference
0.89 (0.81,
1
0.97)
Model
0.90 (0.82,
2
0.99)
Unable to Pay Medical Bills at All
Model
Reference
0.83 (0.74,
1
0.93)
Model
0.89 (0.78,
2
1.01)

Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor; OR, odds ratios; CI, conﬁdence interval.
Model 1: unadjusted model.
Model 2: adjusted for age, sex, race/ethnicity, geographic region, comorbidities,
family size, family income, education, and insurance status.

Fig. 3. Title: Prevalence of Cost-Related Barriers to Health among Non-Elderly
Adults by ASCVD and Non-ASCVD/CRF Proﬁle Status.
There was a stepwise increase in cost-related medication non-adherence, foregone/delayed care, and high ﬁnancial distress with worsening CRF proﬁle.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.

Our current study adds to the existing literature by documenting
signiﬁcantly lower ﬁnancial hardship measures among those with a
favorable CRF status. Findings from our study reiterate the advantages
conferred by an optimal CRF proﬁle beyond lower incidence and mortality from chronic diseases (including diabetes [18], cancer [19,20],
end-stage renal disease [21], and cardiovascular disease [22,23]) and
lower healthcare expenditures and resource utilization [7–9,24]. Our
results further emphasize the importance of preventing and managing
modiﬁable risk factors, irrespective of underlying CVD status for the
overall health at individual, family, and community levels, in addition to
the economic beneﬁts at the national level.
Our ﬁndings also provide insights that secondary prevention among
individuals with ASCVD is equally important as primordial prevention in
protecting one’s family from ﬁnancial burden and other cost-related

barriers to accessing healthcare services. In our study, we demonstrated that, among individuals with ASCVD, those with optimal CRF
proﬁle had signiﬁcantly lower odds of these cost-related consequences
than those with poor CRF proﬁle. These ﬁndings underscore the importance of closely managing cardiovascular risk factors and behaviors
among those with ASCVD to improve the overall cardiovascular health
and ﬁnancial stability of an individual and his or her family.
The management costs of ASCVD are substantial and constitute a
major source of concern at both the national and individual level. While,
attainment of an optimal CRF proﬁle is associated with an overall relative
5
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Fig. 4. Title: Prevalence of Cost-Related Barriers to Health by (A), family income (B), insurance status among Non-Elderly Adults by ASCVD and Non-ASCVD/CRF
Proﬁle Status.
Within each CRF proﬁle strata, individuals with lower income and lack of insurance had a higher prevalence of cost-related medication non-adherence, foregone/
delayed care, and high ﬁnancial distress when compared with individuals with higher income and insurance coverage.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.

Table 4
Odds ratios of cost-related barriers to health among non-elderly adults by ASCVD
and non-ASCVD/CRF proﬁle status.
ASCVD

OR (95%
CI)

of insurance coverage and further limiting out-of-pocket expenditures for
the most vulnerable segments of our society. Further, it is critical to
carefully evaluate the complex, multidirectional interplay between
ﬁnancial hardship, cardiovascular risk factors, and social determinants of
health. Considering the heightened risk of cardiovascular risk factors,
comorbidities, and adverse cardiac events and outcomes among individuals experiencing ﬁnancial hardship from medical bills, it is
imperative to not only strive to improve CRF proﬁles in the general
population and particularly in low-resource settings, but also to
concurrently address the sociodemographic inequities themselves
through focused public health interventions and effective public policy
reform.
Developing and sustaining effective, patient-centered public health
interventions is critical for alleviating the burden and consequences of
cardiovascular risk factors in vulnerable and low-resource communities.
In recent years, community-based health workers (CBHW) have gained
attention for their ability promote healthy behaviors and positive outcomes in underserved settings. Notably, a systematic review conducted
by Kim and colleagues found that the utilization of CMHW interventions
was associated with signiﬁcant cardiovascular risk reduction and that the
roles of CMHW’s included health education, counseling, case management, social services, and support [25]. Another review of the current
literature found that the most commonly implemented community-based
cardiovascular interventions included education followed by counseling
or support and exercise classes, with more than half of interventions
having multiple components [26]. Behavior change interventions were
found to be the most challenging to implement while programs developed to decrease blood pressure were the most effective. Future research
studies and public health interventions may derive beneﬁt from integrating components of the conceptual framework on patient centered
access to healthcare produced by Khanassov et al. describing core tenants
of improving healthcare access in low-resource settings such as
approachability, acceptability, availability, and affordability [27].
Our results should be interpreted given the following limitations. The
cross-sectional nature of our study precludes the establishment of causal
relationship between our studied outcomes and ASCVD or poor CRF
proﬁle status. For example, poor cardiovascular health can predispose a

No ASCVD
Poor CRF
Proﬁle

Average CRF
Proﬁle

Optimal CRF
Proﬁle

OR (95% CI)

OR (95% CI)

OR (95% CI)

0.58 (0.52, 0.63)

0.32 (0.29, 0.36)

0.66 (0.59, 0.73)

0.42 (0.38, 0.48)

0.53 (0.49, 0.57)

0.30 (0.27, 0.32)

0.63 (0.58, 0.69)

0.41 (0.37, 0.45)

0.65 (0.60, 0.71)

0.35 (0.32, 0.38)

0.79 (0.72, 0.87)

0.52 (0.47, 0.58)

Cost-Related Medication Non-Adherence
Model
Reference
0.86 (0.77,
1
0.97)
Model
0.91 (0.80,
2
1.03)
Foregone/Delayed care
Model
Reference
0.86 (0.78,
1
0.95)
Model
0.94 (0.84,
2
1.04)
High Financial Distress
Model
Reference
0.94 (0.85,
1
1.03)
Model
1.02 (0.91,
2
1.14)

Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor; OR, odds ratios; CI, conﬁdence interval.
Model 1: Unadjusted Model.
Model 2: adjusted for age, sex, race/ethnicity, geographic region, comorbidities,
family size, family income, education, and insurance status.

reduction in ﬁnancial hardship, we noted greater burden among those
who lacked health insurance and those with lower family income. In fact,
uninsured and lower income individuals with optimal CRF reported
similar burden of ﬁnancial hardship such as an inability to pay medical
bills, CRN, foregone medical care, and ﬁnancial distress as compared to
insured and middle/high incomes individuals with established ASCVD.
Our study results provide an impetus for health policy advocates and
other stakeholders on the beneﬁts of an upfront investment in ASCVD
primordial and primary prevention. However, the signiﬁcant risk of
ﬁnancial hardship cannot be fully addressed without widening the scope
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family to overall ﬁnancial hardship due to excessive out-of-pocket
healthcare costs, while similarly ﬁnancial hardship from medical bills
may be a contributor to ﬁnancial difﬁculties for any given individual or
family, predisposing to poor cardiovascular health. Therefore, a bilateral
causal relationship is plausible, and it is crucial to note that ﬁnancial
hardship and poor cardiovascular health can cause and progressively
worsen each other with poor social determinants of health serving as the
root cause for either of them. This can be explained by the higher prevalence of ASCVD, poor CRF proﬁle as well as ﬁnancial hardship from
medical bills and other cost-related barriers to health among lower socioeconomic (lower education and income) and uninsured families in our
study. Second, since all the information regarding the study variables was
obtained through self-reported surveys, there is a potential for recall bias.
Therefore, underestimation of the true national prevalence of ASCVD and
modiﬁable risk factor status is likely, as described previously, especially
in chronic conditions [28]. Third, we were unable to calculate the ideal
CVH status as deﬁned by American Heart Association due to lack of dietary information and clinical values of other relevant health factors.
In conclusion, we found that a favorable CRF proﬁle is directly
associated with a signiﬁcantly lower prevalence of ﬁnancial hardship
from medical bills and other cost-related barriers to health, ﬁndings that
support nationwide policies focusing on preventing and managing
modiﬁable risk factors, irrespective of underlying CVD status.
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